Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    Medical Dialogues Bureau
    Medical Dialogues Bureau

      Medical Dialogues Bureau consists of a team of passionate medical/scientific writers, led by doctors and healthcare researchers.  Our team efforts to bring you updated and timely news about the important happenings of the medical and healthcare sector. Our editorial team can be reached at editorial@medicaldialogues.in. Check out more about our bureau/team here

      • Home
      • Medical Dialogues...

      Articles By : Medical Dialogues Bureau

      Biohaven Nurtec™ ODT (rimegepant) launch in US market for migraine  in adults

      Biohaven Nurtec™ ODT (rimegepant) launch in US market for migraine in adults

      Medical Dialogues Bureau16 March 2020 9:00 AM IST
      Treatment with NURTEC ODT is simple – a single dose of 75 mg provides fast pain relief, returns patients to normal function within one hour, and...
      Roche gets USFDA Emergency Use Authorization for its Cobas SARS-CoV-2 Test

      Roche gets USFDA Emergency Use Authorization for its Cobas SARS-CoV-2 Test

      Medical Dialogues Bureau15 March 2020 12:49 PM IST
      Basel: Roche has announced that the U.S. Food and Drug Administration (FDA) has issued an Emergency Use Authorization (EUA) for the cobas® SARS-CoV-2...
      CDSCO updates procedure for issuance of WHO GMP

      CDSCO updates procedure for issuance of WHO GMP

      Medical Dialogues Bureau15 March 2020 12:45 PM IST
      New Delhi: Through a recent notice Central Drugs Standard Control Organization (CDSC0), Directorate General of Health Services, has laid...
      Accelerating Biopharmaceutical development: Dr Harsh Vardhan informs parliament about National Biopharma Mission

      Accelerating Biopharmaceutical development: Dr Harsh Vardhan informs parliament about National Biopharma Mission

      Medical Dialogues Bureau15 March 2020 11:15 AM IST
      The program is promoting entrepreneurship by supporting small and medium enterprises for indigenous product development and through establishment of...
      Anti-competitive activities: CCI pulls up two pharma cos, Bengal Chemists and Druggists Association

      Anti-competitive activities: CCI pulls up two pharma cos, Bengal Chemists and Druggists Association

      Medical Dialogues Bureau15 March 2020 10:45 AM IST
      the CCI has found that pharmaceutical companies Alkem Laboratories Limited ('Alkem') and Macleods Pharmaceuticals Limited ('Macleods') had an...
      Alkem Laboratories receives EIR from USFDA for Baddi facility

      Alkem Laboratories receives EIR from USFDA for Baddi facility

      Medical Dialogues Bureau15 March 2020 9:15 AM IST
      New Delhi: Drug firm Alkem Laboratories on Friday said the US health regulator has issued an establishment inspection report (EIR) for its...
      Cadila Healthcare BOD approves transfer of Animal Healthcare Business to Zydus Animal Health and Investments Limited

      Cadila Healthcare BOD approves transfer of Animal Healthcare Business to Zydus Animal Health and Investments Limited

      Medical Dialogues Bureau15 March 2020 9:00 AM IST
      New Delhi: Cadila Healthcare Ltd. has recently announced that the Board of Directors at its meeting, has approved the transfer of Animal Healthcare...
      Coronavirus Scare: Minister apprises parliament about the availability of drugs and shortages

      Coronavirus Scare: Minister apprises parliament about the availability of drugs and shortages

      Medical Dialogues Bureau14 March 2020 3:03 PM IST
      Delhi: Through a written reply in the Rajya Sabha Shri. D.V. Sadananda Gowda, Minister for Chemicals & fertilizers informed the parliament that...
      9 Biotechnology parks operative in states, providing support to scientists, SMEs

      9 Biotechnology parks operative in states, providing support to scientists, SMEs

      Medical Dialogues Bureau14 March 2020 2:58 PM IST
      New Delhi: There are 9 Biotechnology parks in various states, Dr Harsh Vardhan, Minister of Science & Technology, Health and Family Welfare and...
      AstraZeneca Pharma India gets DCGI nod for Calquence-Acalabrutinib 100mg capsules

      AstraZeneca Pharma India gets DCGI nod for Calquence-Acalabrutinib 100mg capsules

      Medical Dialogues Bureau14 March 2020 12:03 PM IST
      Acalabrutinib 100mg capsules are indicated for the treatment of patients with chronic lymphocytic leukaemia (CLL)/ small lymphocytic lymphoma (SLL).
      Coronavirus Update: Sanitizers, surgical masks, n95 masks, gloves brought under Essential Commodities Act

      Coronavirus Update: Sanitizers, surgical masks, n95 masks, gloves brought under Essential Commodities Act

      Medical Dialogues Bureau14 March 2020 11:32 AM IST
      Both masks (2ply & 3 ply surgical masks, N95 masks) and hand sanitisers have been brought under Essential Commodities Act, 1955, empowering States to...
      Janssen pharma collaborates with Beth Israel Deaconess Medical Center for COVID-19 Vaccine Development

      Janssen pharma collaborates with Beth Israel Deaconess Medical Center for COVID-19 Vaccine Development

      Medical Dialogues Bureau14 March 2020 9:30 AM IST
      Janssen's vaccine program will use the Janssen AdVac® and PER.C6® technologies that provide the ability to rapidly upscale production of an optimal...
      PrevNext

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok